Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy
โ Scribed by R. A. Joss; R. L. Galeazzi; K. W. Brunner
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 580 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Tropisetron (Navobanยฎ, Sandoz Pharma Ltd., Basel, Switzerland), a selective antagonist of the serotonin receptor (5โHT3) dosed onceโdaily at 0.2 mg/kg (with a maximum of 5 mg daily), was evaluated in the prevention of chemotherapyโinduced nausea and vomiting in 131 children with a media
Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n
Tropisetron in the Prevention of Nausea and Vomiting in 131 Children Receiving Cytotoxic Chemotherapy I have read with interest the report by Benoit et al. [1] were two infants. I agree with the authors that the efficacy and safety data was similar to those reported for older concerning the efficacy